Sirona Medical Raises $40M Series D as Platform Usage Triples
Round led by Avidity Partners. Platform usage, ARR, & contracted ARR all grew by more than 2.5x year-over-year.…
New composite outcomes data show patients treated with Lilly’s Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn’s disease at one year
In LUCENT-2, more than one in four (27.7%) Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a…
Lilly’s triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6…
Bloomberg’s Big Take Podcast Spotlights Growing Artificial Stone Silicosis Crisis
NOVATO, Calif., Sept. 29, 2026 /PRNewswire/ — Brayton Purcell LLP is highlighting a recent episode of Bloomberg’s Big…
Study Evaluates Dental Suction Devices for Reducing Oral Surgical Fire Risk
“This study aims to compare the adequacy of the high volume evacuation (HVE), Yankauer (YS), and saliva ejector…
Oracle and Buck Institute for Research on Aging Advance Landmark Federal Aging Research Initiative
Buck Institute aims to advance bioinformatics using Oracle Life Sciences Data Intelligence to transform aging research into a…
Franchise Equity Partners Acquires Bravo Fit, Planet Fitness’ Australian Franchisee
Investment Advances Planet Fitness’ Commitment to Providing Accessible and Affordable Fitness Internationally and Targets Over 135 Planet Fitness…
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
AtaiBeckley’s lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression Acquisition expands Lilly’s neuroscience pipeline…
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
Mississauga, ON, July 15, 2026 /PRNewswire/ – Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare…
Planet DDS and Truro Bring Predictive Intelligence to the Denticon Ecosystem: Transforming Patient-Facing Dental Operations for Capacity and Revenue Optimization
“I’m incredibly excited about our partnership with Truro AI because it solves a problem that has frustrated dental…
BillionToOne’s Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study
Tissue-free ctDNA monitoring was the dominant independent predictor of survival across 12 tumor types and two prospective cohorts…
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney…